semaglutide shot weight loss Shines as Therapy Medical Weight Loss Services -

We report a rare case of acute SBO due to a bezoar in a 65-year-old woman who had been on semaglutide, a Glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss

GLP-1 for People with Celiac Disease: patient experience guidance on patient experience, with safety context, decision points, and practical next steps.

No injections required

Shapsis for his expertise, personalized care, and competitive pricing

Today our partner Amylyx Pharmaceuticals shared exciting news: the nomination of AMX0318 as a development candidate - a novel, long-acting GLP-1 receptor antagonist identified through our collaboration

Retatrutide, an investigational GIP, GLP-1, and GCG receptor agonist, holds promise for weight reduction in adults